Taylor, P., Keystone, E., Van der Heijde, D., Weinblatt, M., del Carmen Morales, L., Reyes Gonzaga, J., . . . Tanaka, Y. (2017). Baricitinib versus placebo or adalimumab in rheumatoid arthritis. Massachusetts Medical Society.
Chicago Style (17th ed.) CitationTaylor, P., et al. Baricitinib Versus Placebo or Adalimumab in Rheumatoid Arthritis. Massachusetts Medical Society, 2017.
MLA (9th ed.) CitationTaylor, P., et al. Baricitinib Versus Placebo or Adalimumab in Rheumatoid Arthritis. Massachusetts Medical Society, 2017.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.